布地奈德、孟鲁司特联合治疗儿童上气道咳嗽综合征的效果分析

Effect Analysis on Budesonide and Montelukast Combined Treatment for Upper Airway Cough Syndrome in Children

目的:探究布地奈德、孟鲁司特联合治疗儿童上气道咳嗽综合征的效果分析。方法:将我院2019年1月-2020年8月收治的84例上气道咳嗽综合征的患儿纳入研究,按照治疗方法的不同分为观察组和对照组,各42例,其中对照组患者选择常规抗组胺药治疗,观察组患者选择布地奈德雾化吸入联合孟鲁司特实施治疗,对比两组患儿的治疗效果。结果:经过治疗后发现,观察组患儿的咳嗽缓解时间、鼻部症状缓解时间以及咽部症状缓解时间均优于对照组,差异有统计学意义(P<0.05);观察组临床疗效为95.23%,明显优于对照组的69%,差异有统计学意义(P<0.05)。结论:针对于儿童上气道咳嗽综合征,选择布地奈德联合孟鲁司特进行治疗,能有效缓解临床症状,提升临床治疗效果,疗效确切,值得临床推广和借鉴。

Objective:To explore the effect of budesonide combined with montelukast in the treatment of upper airway cough syndrome in children.Methods:A total of 84 children with upper airway cough syndrome who were admitted to our hospital between January 2019 and August 2020 were included in the study.According to the different treatment methods,they were divided into observation group and control group,with 42 cases in each group.The control group was treated with conventional antihistamine,and the observation group was treated with budesonide nebulized inhalation combined with oral montelukast.The treatment effect of children in the two groups was compared.Results:After treatment,the cough relief time,nasal symptom relief time,and pharynx symptom relief time of children in the observation group were better than those in the control group,and the difference was statistically significant(P<0.05);the clinical efficacy of the observation group was 95.23%,which was significantly better than that of the control group 69%,and the difference was statistically significant(P<0.05).Conclusion:For children with upper airway cough syndrome,the application of budesonide combined with montelukast for treatment can effectively relieve clinical symptoms,improve clinical treatment effects,and have a definite efficacy.It is worthy of clinical promotion and reference.